160 related articles for article (PubMed ID: 20480198)
21. [Intracranial hypertrophic pachymeningitis with high perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) occurred in a patient on hemodialysis].
Tajima Y; Miyazaki Y; Sudoh K; Matumoto A
Rinsho Shinkeigaku; 2002 Mar; 42(3):243-6. PubMed ID: 12474297
[TBL] [Abstract][Full Text] [Related]
22. Idiopathic hypertrophic pachymeningitis: clinical, laboratory and neuroradiologic features in China.
Zhao M; Geng T; Qiao L; Shi J; Xie J; Huang F; Lin X; Wang J; Zuo H
J Clin Neurosci; 2014 Jul; 21(7):1127-32. PubMed ID: 24589555
[TBL] [Abstract][Full Text] [Related]
23. Hypertrophic cranial pachymeningitis causing progressive unilateral blindness: MR findings.
Shintani S; Shiigai T; Tsuruoka S
Clin Neurol Neurosurg; 1993 Mar; 95(1):65-70. PubMed ID: 8453819
[TBL] [Abstract][Full Text] [Related]
24. A Case of MPO-ANCA-Positive Hypertrophic Cranial Pachymeningitis with Spinal Dura Mater Involvement and Cranial Venous Sinus Thrombosis.
Yao S; Liu Y; Sun Q; Qi L; Liu X
Neurol India; 2023; 71(4):807-809. PubMed ID: 37635533
[No Abstract] [Full Text] [Related]
25. [Hypertrophic pachymeningitis, glomerulonephritis and P-ANCA associated small vessel vasculitis].
Mazzocchi O; Risso JA; Viozzi F; Apa NP; Peralba MC; Nadal MA; De Rosa GE
Medicina (B Aires); 2007; 67(2):151-5. PubMed ID: 17593600
[TBL] [Abstract][Full Text] [Related]
26. Hypertrophic pachymeningitis with anti-neutrophil cytoplasmic antibody (p-ANCA), and diabetes insipidus.
Takuma H; Shimada H; Inoue Y; Ishimura E; Himuro K; Miki T; Nishizawa Y
Acta Neurol Scand; 2001 Dec; 104(6):397-401. PubMed ID: 11903097
[TBL] [Abstract][Full Text] [Related]
27. [Unusual visual impairments in a case of MPO-ANCA associated hypertrophic pachymeningitis].
Hayashi S; Sugeno N; Nishiyama S; Hasegawa T; Aoki M
Rinsho Shinkeigaku; 2012; 52(3):152-5. PubMed ID: 22453038
[TBL] [Abstract][Full Text] [Related]
28. Case of infiltrative optic neuropathy with hypertrophic pachymeningitis as a manifestation of en plaque meningioma.
Lin SZZ; Lizwan M; Tan MB; Sonu SK
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38081732
[TBL] [Abstract][Full Text] [Related]
29. Hypertrophic spinal pachymeningitis caused by ANCA-associated vasculitis revealed by 18F-FDG PET/CT: A case report.
Wu M; Ren J; Luo Y
Medicine (Baltimore); 2021 Jan; 100(3):e24388. PubMed ID: 33546079
[TBL] [Abstract][Full Text] [Related]
30. Optic Neuropathy with Headache and Palpable Temporal Arteries Due to Hypertrophic Pachymeningitis Rather than Giant Cell Arteritis.
Nakajima I; Taniguchi Y; Mizobuchi T; Kishimoto T; Fukushima A; Fukuda K
Ocul Immunol Inflamm; 2022 Aug; 30(6):1515-1518. PubMed ID: 33793376
[No Abstract] [Full Text] [Related]
31. Multiple cranial nerve palsy revealing hypertrophic pachymeningitis with positive myeloperoxidase-antineutrophil cytoplasmic antibody.
El Aoud S; Frikha F; Ben Salah R; Snoussi M; Loukil H; Bahloul Z
Reumatismo; 2013 Dec; 65(5):248-52. PubMed ID: 24399188
[TBL] [Abstract][Full Text] [Related]
32. ANCA-negative granulomatosis with polyangiitis presenting with orbital apex syndrome and recurrent pachymeningitis: A case report.
Hisahara S; Yamada M; Matsuura Y; Tsuda E; Akiyama Y; Saitoh M; Kawamata J; Mikuni N; Shimohama S
J Neurol Sci; 2016 Sep; 368():175-7. PubMed ID: 27538627
[No Abstract] [Full Text] [Related]
33. [A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated hypertrophic pachymeningitis presenting with multiple cranial nerve palsies and diabetes insipidus].
Yasuda K; Sainouchi M; Goto M; Murase N; Ohtani R; Nakamura M
Rinsho Shinkeigaku; 2016 May; 56(5):334-7. PubMed ID: 27098904
[TBL] [Abstract][Full Text] [Related]
34. [Case of cerebral venous thrombosis caused by MPO-ANCA associated hypertrophic pachymeningitis].
Saito T; Fujimori J; Yoshida S; Kaneko K; Kodera T
Rinsho Shinkeigaku; 2014; 54(10):827-30. PubMed ID: 25342019
[TBL] [Abstract][Full Text] [Related]
35. Pachymeningitis in microscopic polyangiitis (MPA): a case report and a review of central nervous system involvement in MPA.
Kono H; Inokuma S; Nakayama H; Yamazaki J
Clin Exp Rheumatol; 2000; 18(3):397-400. PubMed ID: 10895382
[TBL] [Abstract][Full Text] [Related]
36. Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody.
Yokoseki A; Saji E; Arakawa M; Kosaka T; Hokari M; Toyoshima Y; Okamoto K; Takeda S; Sanpei K; Kikuchi H; Hirohata S; Akazawa K; Kakita A; Takahashi H; Nishizawa M; Kawachi I
Brain; 2014 Feb; 137(Pt 2):520-36. PubMed ID: 24271323
[TBL] [Abstract][Full Text] [Related]
37. [A case of MPO-ANCA positive hypertrophic pachymeningitis associated with vascular inflammation in the kidney biopsy].
Takewaki D; Tsuji Y; Kasai T; Yoshida T; Nakagawa M; Mizuno T
Rinsho Shinkeigaku; 2015; 55(11):844-7. PubMed ID: 26458570
[TBL] [Abstract][Full Text] [Related]
38. Reversible Sensorineural Hearing Loss due to Pachymeningitis Associated with Elevated Serum MPO-ANCA.
Lim EJ; Kim SH; Lee SH; Lee KY; Choi JH; Nam EJ; Lee SH
Clin Exp Otorhinolaryngol; 2011 Sep; 4(3):155-8. PubMed ID: 21949583
[TBL] [Abstract][Full Text] [Related]
39. Recurrent cranial neuropathy as a clinical presentation of idiopathic inflammation of the dura mater: a possible relationship to Tolosa-Hunt syndrome and cranial pachymeningitis.
Miwa H; Koshimura I; Mizuno Y
J Neurol Sci; 1998 Jan; 154(1):101-5. PubMed ID: 9543331
[TBL] [Abstract][Full Text] [Related]
40. [Hypertrophic pachymeningitis and ophthalmological disturbances: description of two case reports].
Pareja-Esteban J; Gutiérrez-Solana S; Cedazo M; Sánchez-Cordón B; Gamo-Gallego M; Teus MA
Arch Soc Esp Oftalmol; 2008 Aug; 83(8):497-500. PubMed ID: 18661447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
